| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 03/06/2002 | EP1183348A2 Compositions for the treatment and diagnosis of breast cancer and methods for their use |
| 03/06/2002 | EP1183347A1 Interaction-activated proteins |
| 03/06/2002 | EP1183344A2 Adam polynucleotides and polypeptides |
| 03/06/2002 | EP1183331A2 Undifferentiated erythroid cells and their use in ligand binding assays |
| 03/06/2002 | EP1183330A1 Kv10.1, A NOVEL VOLTAGE-GATED POTASSIUM CHANNEL FROM HUMAN BRAIN |
| 03/06/2002 | EP1183329A2 Differentiated human embryoid cells and a method for producing them |
| 03/06/2002 | EP1183328A2 Microcellular polymers as cell growth media and novel polymers |
| 03/06/2002 | EP1183272A2 49 human secreted proteins |
| 03/06/2002 | EP1183270A2 Novel organic anion transport proteins |
| 03/06/2002 | EP1183040A1 Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway |
| 03/06/2002 | EP0848757B1 The use of the wap of mmtv regulatory sequences for targeted expression of linked heterologous genes in human mammary cells, including human mammary carcinoma cells |
| 03/06/2002 | EP0710110B1 Antibodies of ring opened rapamycins |
| 03/06/2002 | EP0691400B1 Process for embedding culture of animal cells |
| 03/06/2002 | CN1339107A Method of identifying N-terminal proBNP |
| 03/06/2002 | CN1339067A Synthetic and chimeric promoters, expresion cassettes, plasmids, vectors, transgenic plants and seeds containing them, and method for producing them |
| 03/06/2002 | CN1339066A Alzheimer's disease secretase |
| 03/06/2002 | CN1339063A Human hybrid host cell for mammalian gene expression |
| 03/06/2002 | CN1338512A Human liver cancer cell line |
| 03/06/2002 | CN1080312C Rapamycin assay |
| 03/06/2002 | CN1080311C Peptide related to human programmed cell death and DNA cencoding it |
| 03/06/2002 | CN1080305C Preparation of hepatocellular cearcinoma oncogene |
| 03/06/2002 | CN1080300C Process for growing porcine reproductive and respiratory syndrome virus and its use in vaccines |
| 03/06/2002 | CN1080130C In vitro conea equivalent model |
| 03/05/2002 | US6353154 Nucleic acid molecules encoding starch phosphorylase from maize |
| 03/05/2002 | US6353153 Enhanced transport with a plastid membrane transport protein |
| 03/05/2002 | US6353093 gidB |
| 03/05/2002 | US6353092 Patched-2 polypeptide |
| 03/05/2002 | US6353089 Stimulating proliferation of cytotoxic lymphocytes cells by exposing a fluid sample with a major histocompatability complex and incubate to allow lysis of the presenting cells |
| 03/05/2002 | US6352971 Polypeptides with amino acid sequences |
| 03/05/2002 | US6352846 A polypeptide; for transgenic plants with increased crop yields |
| 03/05/2002 | US6352832 Anti-CCR2 antibodies and methods of use therefor |
| 03/05/2002 | US6352694 Immunotherapy; biochemical immobilization; genetic engineering; medical diagnosis |
| 03/05/2002 | US6352555 Methods for implanting cells |
| 03/05/2002 | US6352513 Personal cervical cell collector |
| 03/05/2002 | CA2356553A1 Identification of a capacitative calcium channel in antigen presenting cells and uses thereof |
| 03/05/2002 | CA2145290C Methods and compositions for controlling translation of hcv proteins |
| 02/28/2002 | WO2002016944A2 Synthetic nucleic acid molecule compositions and methods of preparation |
| 02/28/2002 | WO2002016638A1 METHOD FOR IDENTIFYING SUBSTANCES USEFUL FOR TREATING INFLAMMATION USING THE RESPONSE ELEMENT TO THE IλBα ROR RECEPTOR |
| 02/28/2002 | WO2002016625A2 Plant polynucleotides encoding prenyl proteases |
| 02/28/2002 | WO2002016620A2 Modulation of stem cell differentiation |
| 02/28/2002 | WO2002016612A2 Genes and proteins, and their uses |
| 02/28/2002 | WO2002016611A2 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 02/28/2002 | WO2002016604A1 Method of accumulating foreign gene product in plant seed at high level |
| 02/28/2002 | WO2002016597A2 Lipid metabolism enzymes |
| 02/28/2002 | WO2002016595A2 Kidney-specific protein |
| 02/28/2002 | WO2002016594A2 Methods and reagents for molecular cloning |
| 02/28/2002 | WO2002016587A2 Microtubule-associated proteins and tubulins |
| 02/28/2002 | WO2002016585A2 Imidazoline receptor homologs |
| 02/28/2002 | WO2002016584A2 Process for the preparation of neutrophil inhibitory factor |
| 02/28/2002 | WO2002016583A2 Constructs and their use in metabolic pathway engineering |
| 02/28/2002 | WO2002016567A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 02/28/2002 | WO2002016566A2 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 02/28/2002 | WO2002016561A2 Mfq-111, a novel human gtpase like protein |
| 02/28/2002 | WO2002016560A1 Method for producing ready to use, antigen loaded or unloaded, cryoconserved mature dendritic cells |
| 02/28/2002 | WO2002016559A2 In vivo animal model of human leukemia |
| 02/28/2002 | WO2002016557A2 Tissue engineering scaffolds promoting matrix protein production |
| 02/28/2002 | WO2002016555A2 Htert-immortalised cell lines, their preparation and use |
| 02/28/2002 | WO2002016433A2 Two receptors of meiosis activating sterols designated sam1a and sam1b |
| 02/28/2002 | WO2002016419A2 Progression suppressed gene 13 (psgen 13) and uses thereof |
| 02/28/2002 | WO2002016417A2 Transgenic animal model for neurodegerative disease and uses thereof |
| 02/28/2002 | WO2002016416A2 Diagnosis and treatment of cardiovascular conditions |
| 02/28/2002 | WO2002016415A2 Identification of a cam-kinase ii inhibitor |
| 02/28/2002 | WO2002016413A2 Cripto tumour polypeptide |
| 02/28/2002 | WO2002016385A1 Novel tumor suppressor encoding nucleic acid, ptx1, and methods of use thereof |
| 02/28/2002 | WO2002016365A1 Pyrazole compounds, pharmaceutical compositions, and methods for modulating or inhibiting erab or hadh2 activity |
| 02/28/2002 | WO2002015952A1 Scaffolds for tissue engineered hair |
| 02/28/2002 | WO2002015939A2 Calycins |
| 02/28/2002 | WO2002015927A1 High mannose proteins and methods of making high mannose proteins |
| 02/28/2002 | WO2002015914A1 Vascularised tissue graft |
| 02/28/2002 | WO2002015846A2 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders |
| 02/28/2002 | WO2002015701A2 Bacillus thuringiensis crystal protein hybrids |
| 02/28/2002 | WO2002015680A1 Type iii allergic inflammation model animal |
| 02/28/2002 | WO2002010372A8 Method of producing functional protein domains |
| 02/28/2002 | WO2001085779A3 Protein complexes and assays for screening anti-cancer agents |
| 02/28/2002 | WO2001085762A3 Cancer diagnosis and assays for screening anti-cancer agents |
| 02/28/2002 | WO2001085196A3 Cxcr4 antagonist treatment of hematopoietic cells |
| 02/28/2002 | WO2001081380A3 Immunogenic pneumococcal protein and vaccine compositions thereof |
| 02/28/2002 | WO2001079271A9 Albumin fusion proteins |
| 02/28/2002 | WO2001079258A9 Albumin fusion proteins |
| 02/28/2002 | WO2001078796A9 Type ii gonadotropin-releasing hormone receptor and polynucleotides encoding therefor |
| 02/28/2002 | WO2001075064A3 Method and materials relating to insulin-like growth factor binding protein-like polypeptides and polynucleotides |
| 02/28/2002 | WO2001074378A3 Promoting cell growth by inhibiting enabled proteins or their ligands |
| 02/28/2002 | WO2001073029A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 02/28/2002 | WO2001072970A3 Methods to prepare and use epidermal stem cells |
| 02/28/2002 | WO2001070984A3 Anti-tissue factor antibodies with enhanced anticoagulant potency |
| 02/28/2002 | WO2001068852A3 Apolipoprotein-a-i regulation of t-cell signalling |
| 02/28/2002 | WO2001064847A3 In vitro modification of cardiac valvular xenografts |
| 02/28/2002 | WO2001062895A3 Simultaneous stimulation and concentration of cells |
| 02/28/2002 | WO2001055345A3 Method for producing a serum-containing culture medium for cells and the use thereof |
| 02/28/2002 | WO2001053339A3 Egg specific surface proteins |
| 02/28/2002 | WO2001042474A3 Interferon-like molecules and uses thereof |
| 02/28/2002 | WO2001040444A3 Method and compositions for producing cell transplants |
| 02/28/2002 | WO2001038500A3 Tetrahydropyrimidine oxygenase gene, polypeptides encoded by said gene and method for producing the same |
| 02/28/2002 | WO2001032702A3 Molecular structure of rhd negative locus |
| 02/28/2002 | WO2001031029A3 Human sphingosine kinase gene |
| 02/28/2002 | WO2001030812A3 Activation of hcv-specific t cells |
| 02/28/2002 | WO2001027284A3 Recombinant megalomicin biosynthetic genes and uses thereof |
| 02/28/2002 | WO2001023414B1 Immunologically significant herpes simplex virus antigens |
| 02/28/2002 | WO2001015755A3 Methods and compositions for delivery of pharmaceutical agents |
| 02/28/2002 | WO2000077037A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |